Impact of IMWG Frailty and Nutritional Biomarkers on Outcomes in MM Pts Undergoing ASCT

Key Points

• Outcomes are significantly influenced by frailty and nutritional biomarkers in multiple myeloma patients undergoing ASCT.
• Key evidence shows that patients with higher frailty scores experienced worse outcomes compared to less frail patients.
• Observational analysis assessed the relationship between frailty, nutritional markers, and treatment outcomes in a multiple myeloma cohort.
• Implications highlight the need for nutritional support and frailty assessment to improve treatment strategies in this population.